Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and … – Markets Insider
|
Inovio's Cancer Immunotherapy (INO-5150) Slowed PSA Rise and …
Markets Insider PLYMOUTH MEETING, Pa., Sept. 11, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that an interim data analysis … |
